This is the 5^th in a series of blog posts about the 10^th September SIGN draft guideline day on "Non-pharmacological management of depression."  On the day, the

The SIGN draft guideline day on "Non-pharmacological management of mild to moderate depression" last Wednesday continued with two further presentations in this first section on "Lifestyle and Alternative/Complementary Therapies 1".  After the "grade A" recommendations on exercise and St John's Wort given during the first two presentations (covered in the two previous blog posts), the rest of this section felt a bit of an anticlimax.

This is the third in a series of blog posts on last Wednesday's SIGN draft guideline seminar on "Non-pharmacological management of mild to moderate depression."  The first session of the day was on "Lifestyle and Alternative/Complementary Therapies 1".  Yesterday's blog discussed the first presenter, Ian Ross's talk on the value of exercise in depression.  The second presentation was by Cliff Sharp, a psychiatrist from NHS borders.  He reviewed St John's Wort & Dietary Supplements.  He talked about the possible value of folate in treating depression when used to supplement conventional antidepressants.  He concluded that current evidence was insufficient to determine whether folate boosts response for those on antidepressants only if their initial folate levels are low, or whether it boosts response for anyone taking antidepressants.  See an

I described the work of UK's National Institute for Health and Clinical Excellence (NICE) in an

The UK National Institute for Health and Clinical Excellence is "the independent organisation responsible for providing national guidance on the promotion of good health and the prevention and tr